Related Experiment Video
Updated: Apr 26, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Improving lipid control following myocardial infarction
Jyoti Ankam1, David I Feldman, Michael J Blaha
1Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland, USA.
Insights
Optimizing lipid control after myocardial infarction is crucial for reducing recurrent cardiovascular events. Early high-intensity statin therapy, alongside lifestyle changes and adherence support, improves patient outcomes.
Area of Science:
- Cardiology
- Lipidology
- Preventive Medicine
Background:
- Myocardial infarction and dyslipidemia are major global health burdens.
- Effective lipid management post-myocardial infarction is vital for preventing secondary events.
- Current clinical practice shows room for improvement in lipid control strategies.
Purpose of the Study:
- To review current research and perspectives on enhancing lipid control after myocardial infarction.
- To identify key factors influencing post-myocardial infarction lipid management.
- To highlight strategies for optimizing patient outcomes.
Main Methods:
- Review of recent studies and implementation science findings.
- Analysis of patient-level, provider-level, and healthcare system-level factors.
- Identification of effective tools and interventions for lipid management.
Main Results:
- Suboptimal use of early high-intensity statin therapy and overall lipid control noted.
- Lipid control has shown improvement over the past decade.
- Checklists are effective tools, prioritizing early high-intensity statin therapy, smoking cessation, cardiac rehabilitation, lifestyle counseling, medication adherence, and ongoing surveillance.
Conclusions:
- Optimizing lipid control post-myocardial infarction can significantly improve clinical outcomes.
- A multifaceted approach including statin therapy, lifestyle modifications, and adherence support is essential.
- Further research and implementation efforts are needed to enhance lipid management.
Purpose Of Review:
Following a myocardial infarction, lipid-lowering therapy is an established intervention to reduce the risk of recurrent cardiovascular events. Prior studies show a need to improve clinical practice in this area. Here, we review the latest research and perspectives on improving postmyocardial infarction lipid control.
Recent Findings:
Dyslipidemia and myocardial infarction remain leading causes of global disability and premature mortality throughout the world. The processes of care in lipid control involve multiple patient-level, provider-level, and healthcare system-level factors. They can be challenging to coordinate. Recent studies show suboptimal use of early high-intensity statin therapy and overall lipid control following myocardial infarction. Encouragingly, lipid control has improved over the last decade. Implementation science has identified checklists as an effective tool. At the top of the checklist for reducing atherogenic lipids and recurrent event risk postmyocardial infarction is early high-intensity statin therapy. Smoking cessation and participation in cardiac rehabilitation are also priorities, as are lifestyle counseling, promotion of medication adherence, ongoing lipid surveillance, and medication management.
Summary:
Optimizing lipid control could further enhance clinical outcomes after myocardial infarction.
Related Concept Videos
Angina IV: Management
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Myocarditis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care

